Friday 6 November 2026
Export BYAH’s income statement to Excel — free account
Park Ha Biological Technology Co., Ltd.
BYAH Consumer Defensive Household & Personal Products
Park Ha Biological Technology Co., Ltd.’s revenue for fiscal 2025 (year ended October 2025) was $2.5 million, up 6.00% from fiscal 2024.
2.09
0.17
−7.52%
Follow BYAH
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to October
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Apr ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | 622 | 456 | — | — | — | — | 2 | 2 | 2 | 3 | — | (45.8%) | — | — | — | — | |
| Gross margin, % | 41.96 | 39.25 | — | — | — | — | 87.35 | 87.35 | 91.80 | 94.36 | — | +52.4 pt | ||||||
| EBT | (304) | (273) | — | — | — | — | 1 | (1) | 1 | (24) | — | (24.6%) | ||||||
| EBT margin, % | (48.87) | (59.87) | — | — | — | — | 48.05 | 0.00 | 33.31 | (953.90) | — | (905.0) pt | ||||||
| Net income | 0 | 0 | — | — | — | — | 0 | 0 | 0 | (24) | (45) | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | 0.00 | 0.00 | — | — | — | — | 0.00 | 39.35 | 38.11 | 34.30 | — | n/m | |||||
| Earnings | — | — | — | — | — | — | — | 13.63 | 7.66 | (331.04) | — | n/m | ||||||
| Cash flow | — | — | — | — | — | — | — | 0.00 | 15.37 | 1.17 | 0.00 | n/m | ||||||
| Capex | — | — | — | — | — | — | — | 0.00 | (1.37) | (1.21) | 0.00 | n/m | ||||||
| Free cash flow | — | — | — | — | — | — | — | 0.00 | 14.00 | (0.04) | 0.00 | n/m | ||||||
| Book value | 0.00 | 0.00 | — | — | — | — | 0.00 | 16.20 | 24.10 | 54.28 | 0.00 | n/m | ||||||
| Shares, m | — | — | — | — | — | — | — | 0 | 0 | 0 | — | +8.5% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | — | — | |||||
| P/S | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| P/B | 0.00 | 0.00 | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/Sales | 0.00 | 0.00 | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/FCF | (0.28) | (0.28) | — | — | — | — | (0.28) | (0.28) | (0.28) | (1.90) | (7.30) | (0.6) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | (1) | 1 | 0 | 1 | n/m | |||||
| Capex | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | +97.8% | ||||||
| Free cash flow | — | — | — | — | — | — | — | (1) | 1 | 0 | 1 | (93.8%) | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | 256 | 56 | — | — | — | — | 1 | 1 | 1 | 4 | 5 | (37.7%) | |||||
| Net debt | 299 | (213) | — | — | — | — | (1) | (1) | (1) | (4) | (6) | n/m | ||||||
| Shareholders’ equity | 1,090 | 553 | — | — | — | — | 1 | 1 | 2 | 4 | 5 | (46.4%) | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | (6.36) | (11.98) | — | — | — | — | 37.62 | 25.51 | 20.94 | (539.29) | 0.00 | (532.9) pt | |||||
| ROIC | (2.61) | (15.07) | — | — | — | — | 0.00 | 0.00 | 51.75 | (7,284.30) | 0.00 | (7,281.7) pt | ||||||
| ROE | (94.39) | 7,233.33 | — | — | — | — | (809.89) | 0.00 | 38.01 | (885.83) | 0.00 | (791.4) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 33 | 31 | 40 | — | +10.1% | |||||
| Revenue/emp, $m | 0.00 | 0.00 | — | — | — | — | 0.00 | 0.07 | 0.08 | 0.06 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Oct 2025 · fundamentals updated 26 Oct 2026
Park Ha Biological Technology Co., Ltd. vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| SLSN Solesence, Inc. | $61.2M | — (loss-making) | — | −24.69% (below 0%: shrinking) | n/m | +86.52% (above 0%: growing) | 30.97% | 0.79% | Compare |
| GROV Grove Collaborative Holdings, Inc. | $44.8M | — (loss-making) | — (loss-making) | −16.94% (below 0%: shrinking) | n/m | +101.08% (above 0%: growing) | 53.56% | (2.14%) | Compare |
| UG United-Guardian, Inc. | $31.2M | 12.6× | 18.7× | +9.52% (above 0%: growing) | +14.29% (above 0%: growing) | +428.43% (above 0%: growing) | 49.73% | 24.26% | Compare |
| DSY Big Tree Cloud Holdings Limited | $15.4M | 17.8× | — | — | 0.00% | −267.22% (below 0%: shrinking) | — | — | Compare |
| ATTT Atlas Trinity Tech Limited | $11.9M | — | — | — | — | −192.00% (below 0%: shrinking) | — | — | Compare |
| TANH Tantech Holdings Ltd. | $9.0M | — (loss-making) | 0.7× | −4.32% (below 0%: shrinking) | +102.50% (above 0%: growing) | −214.50% (below 0%: shrinking) | 20.52% | 0.00% | Compare |
| BRSHF Bruush Oral Care Inc. | $8.7M | — (loss-making) | — | +7.78% (above 0%: growing) | n/m | −241.22% (below 0%: shrinking) | 75.64% | (488.63%) | Compare |
| BYAH Park Ha Biological Technology Co., Ltd. | $4.9M | — | — | — | — | −138.75% (below 0%: shrinking) | — | — | |
| XAGE Longevity Health Holdings, Inc. | $1.6M | — (loss-making) | — | −21.37% (below 0%: shrinking) | n/m | +73.22% (above 0%: growing) | 59.47% | (182.88%) | Compare |
| Median of peers | $13.7M | — | — | −10.63% | +14.29% | −59.39% | 51.65% | (1.07%) |